Results 231 to 240 of about 9,546,669 (393)

Combination therapy with oncolytic viruses for lung cancer treatment. [PDF]

Front Oncol
Sun L, Zhao Q, Miao L.
europepmc   +1 more source

A combination therapy of CO2 and YAG Laser for Head and Neck cancer

, 1985
Tetsuzo Inoue, Hideo Tomomatsu, Masami Ogura, Junichi Sakata   +3 more
openalex   +2 more sources

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer. [PDF]

Cancer Immunol Res
Gracia-Hernandez M, Maldonado MDM, Schlom J, Hamilton DH.   +3 more
europepmc   +1 more source

Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor [PDF]

, 1992
Joan H. Schiller, Patricia L. Witt, Barry Storer, Dona Alberti, Mary Beth Tombes, Rhoda Arzoomanian, Raymond R. Brown, Richard A. Proctor, Stephan D. Voss, David R. Spriggs, Donald L. Trump, Ernest C. Borden   +11 more
openalex   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

A CASE WITH ADVANCED RENAL CELL CARCINOMA ACHIEVED COMPLETE RESPONSE BY A SEQUENTIAL COMBINATION THERAPY WITH GAMMA INTERFERON AND OK-432 (STREPTOCOCCAL PREPARATION)

, 1988
So Nakamura, Ken Marumo, Taro Shibayama, Shiro Baba, Nobuhiro Deguchi, Hiroshi Tazaki   +5 more
openalex   +2 more sources

Two cases of disseminated trichosporon beigelii infection treated with combination antifungal therapy [PDF]

, 1990
Kíyoyuki Ogata, Yoshihiro Tanabe, Katsuhiko Iwakiri, Toshiharu Ito, Takashi Yamada, Kazuo Dan, T Nomura   +6 more
openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention? [PDF]

Biomolecules
Biglari S, Mischak H, Beige J, Latosinska A, Siwy J, Banasik M.   +5 more
europepmc   +1 more source